Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dapagliflozin in acute myocardial infarction
IRCT20240730062583N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dapagliflozin in myocardial infarction (MI) and heart failure (HF), sponsored by Iran University of Medical Sciences. Started May 2024; status: completed.
02
Drugs
dapagliflozin
03
Conditions
myocardial infarction (MI)heart failure (HF)
Beyond the preview
Go deeper on IRCT20240730062583N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240730062583N1.